Last reviewed · How we verify
NCT01908985
Ocular Fluorophotometry for Glaucoma Treated With Cyclo-coagulation Using High Intensity Focused Ultrasound (HIFU).
trial testing high intensity focused ultrasound for cyclodestruction in the eye in Refractory Open Angle Glaucoma. No longer available.
Quick facts
| Lead sponsor | EyeTechCare |
|---|---|
| Status | NO LONGER AVAILABLE |
| Study type | EXPANDED_ACCESS |
Drugs / interventions tested
- high intensity focused ultrasound for cyclodestruction in the eye
Conditions studied
- Refractory Open Angle Glaucoma — all drugs for Refractory Open Angle Glaucoma →
Sponsor
EyeTechCare
Who can join
18 and older, any sex, with Refractory Open Angle Glaucoma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Monocentric prospective study conducted in two phases evaluating the secretion and elimination of aqueous humor by fluorophotometry in patients with glaucoma treated with cyclo-coagulation with ultrasound. Population selected: \- Patients with refractory open angle glaucoma despite previous treatments currently validated for glaucoma. The purpose of our study is: \- To evaluate the mechanism of action of glaucoma treatment by cyclo-coagulation with high intensity focused ultrasound in studying the secretion and elimination of aqueous humor by fluorophotometry. Planning: * First phase: 2 patients (feasibility study) If reduction of at least 10% of the flow of aqueous humor production at one month in the first two patients in the feasibility study, further in second phase. * Second phase: 6 patients
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT01908985
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other EyeTechCare trials
Trials by the same sponsor.
- NCT04145830 — UCP Glaucoma Treatment for Primary Glaucoma in China · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT01908985 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by EyeTechCare
- Last refreshed: 19 July 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01908985.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing